Neutrophil Elastase/ELA2 Antibody (ELA10-101.5 (39A)) [Janelia Fluor® 585]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-64392JF585
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Functional
Label
Janelia Fluor 585
Antibody Source
Monoclonal Mouse IgG1 Clone # ELA10-101.5 (39A)
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary
Immunogen
Elastase from human neutrophils
Reactivity Notes
Not yet tested in other species.
Localization
Secreted
Specificity
NB100-64392 is specific for human neutrophil elastase.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Neutrophil Elastase/ELA2
Alternate Names
ELA2, ELANE, Elastase-2, Leukocyte Elastase, Medullasin
Gene Symbol
ELANE
Additional Neutrophil Elastase/ELA2 Products
Product Specific Notices
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...